FDA Wants Drug Pulled From Market, Citing Liver Risk. Company Says No.
(MedPage Today) -- The FDA has requested that Amgen voluntarily withdraw avacopan (Tavneos), a treatment for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated ...
Tag: Citing